SCHEMBL23048795

SCHEMBL23048795

Fc1cc(N2CCOCC2)c(-n2cc(C3CC3)nc2S)cc1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAP3K5 Q99683 1/20 0.34
PIK3CA P42336 2/20 0.33
PIK3R1 P27986 1/20 0.33
CNR2 P34972 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
IGF1R P08069 1/20 0.31
HTT P42858 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
MAPT P10636 3/20 0.31
ALDH1A1 P00352 2/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23048789 0.80 MAP3K5 (0.46) MAP3K5AKT1
SCHEMBL23865352 0.76 HCRTR1 (0.30)
SCHEMBL23048746 0.76 MAP3K5 (0.31) MAP3K5
SCHEMBL23865458 0.73 MAP3K5 (0.36) MAP3K5
SCHEMBL23048780 0.72 KDM1A (0.37)
SCHEMBL29173497 0.65 ALDH1A1 (0.50) RAB9ASMN1; SMN2HTTKDM4EMEN1
SCHEMBL29789861 0.65 LGMN (0.50) RAB9ASMN1; SMN2HTTKDM4EMEN1
SCHEMBL20605957 0.65 LGMN (0.50) RAB9ASMN1; SMN2HTTKDM4EMEN1
SCHEMBL21155474 0.65
SCHEMBL14688044 0.65 KDM4E (0.41) RAB9ASMN1; SMN2IRAK4HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3572401-B1 ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN) 2021-09-29 EP disclosed
EP-3572412-B1 PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN) 2021-03-03 EP disclosed